| Pressure Enabled Intrapancreatic Delivery of SD-101 With Checkpoint Blockade for Locally Advanced Pancreatic Adenocarcinoma (NCT05607953) | TriSalus Life Sciences, Inc. | 2023-03-01 |
| A First-in-Human Study of QY211 Gel in Adult Subjects (NCT05843422) | E-nitiate Biopharmaceuticals (Hangzhou) Co., Ltd. | 2023-03-01 |
| Topical Antibiotic Prophylaxis for Nasal Packing Post-ESBS (NCT04946435) | Carl Snyderman | 2023-03-01 |
| Safety, Tolerability, and Immunogenicity of Trivalent Coronavirus Vaccine Candidate VBI-2901e With E6020 Adjuvant (NCT05614245) | VBI Vaccines Inc. | 2023-03-01 |
| Safety and Immunogenicity of Pentavalent Meningococcal Conjugate Vaccine (EuNmCV-5) in Healthy Adults Aged 19 to 55 Years Old (NCT05739292) | EuBiologics Co.,Ltd | 2023-02-28 |
| A Phase Ib/II Clinical Trial to Evaluate the Safety and Efficacy of HLX208+HLX10 in NSCLC With BRAF V600E Mutation (NCT05641493) | Shanghai Henlius Biotech | 2023-02-28 |
| Treatment of Recurrent Glioblastoma With Fractionated Radiotherapy Combined With Cadonilimab (NCT05737368) | Second Affiliated Hospital, Zhejiang University, School of Medicine | 2023-02-28 |
| The Pharmacokinetics (PK), Safety, Tolerability of SR750 in Healthy Volunteers (NCT05753033) | Shanghai SIMR Biotechnology Co., Ltd. | 2023-02-28 |
| An Open-label, Study to Assess Safety, Efficacy and Cellular Kinetics of YTB323 in Severe, Refractory Systemic Lupus Erythematosus (NCT05798117) | Novartis Pharmaceuticals | 2023-02-28 |
| A Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics Of AJ201 In Patients (NCT05517603) | AnnJi Pharmaceutical Co., Ltd. | 2023-02-28 |
| A Study of ASP2074 in Adults With Solid Tumors (NCT05646797) | Astellas Pharma Global Development, Inc. | 2023-02-28 |
| Sublingual Dexmedetomidine for Treating Opioid Withdrawal (NCT05712707) | New York State Psychiatric Institute | 2023-02-28 |
| A Phase 1 Safety, Tolerability, and Pharmacokinetics Study of AMG 794 With Claudin 6-positive Non-small Cell Lung Cancer, Epithelial Ovarian Cancer, and Other Malignant Solid Tumor Indications (NCT05317078) | Amgen | 2023-02-28 |
| A Safety, Tolerability and Efficacy Study of NC525 in Subjects With Advanced Myeloid Neoplasms (NCT05787496) | NextCure, Inc. | 2023-02-28 |
| APG-115 Alone or in Combination With APG-2575 in Recurrent or Refractory Neuroblastoma or Solid Tumors (NCT05701306) | Ascentage Pharma Group Inc. | 2023-02-28 |
| A Safety Study of Pharmacologic Ascorbate and Ferumoxytol in Addition to Standard of Care Chemoradiation in Glioblastoma (NCT04900792) | Bryan Allen | 2023-02-28 |
| A Study of PJ009 in Healthy Adult Volunteers (NCT06523101) | Chongqing Peg-Bio Biopharm Co., Ltd. | 2023-02-28 |
| Concor® Bioequivalence Study in Chinese Participants (Darmstadt-Nantong) (NCT05930808) | Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany | 2023-02-28 |
| A Study Evaluating AHB-137 in Healthy Participants and Participants with Chronic Hepatitis B (NCT05717686) | AusperBio Therapeutics Inc. | 2023-02-28 |
| Study of DECOY20 With or Without Tislelizumab in Patients With Advanced Solid Tumors (NCT05651022) | Indaptus Therapeutics, Inc | 2023-02-28 |
| XmAb23104 (PD1 X ICOS) and XmAb22841 (CTLA-4 X LAG3) in Treating Melanoma Prior Immune Checkpoint Inhibitor Therapy (NCT05695898) | University of California, San Francisco | 2023-02-28 |
| Phase Ib/II Study to Evaluate the Efficacy and Safety of GH509 Versus Placebo in Patients With NASH/NAFLD (NCT05784779) | 1Globe Biomedical Co., Ltd. | 2023-02-28 |
| Effect of Fluconazole on Pharmacokinetics of SHR2554 in Healthy Subjects (NCT05661591) | Jiangsu HengRui Medicine Co., Ltd. | 2023-02-28 |
| NAD Supplementation and Vascular Health in PAD (NCT06534944) | University of Oklahoma | 2023-02-27 |
| A Phase 1/2 Study of VX-522 in Participants With Cystic Fibrosis (CF) (NCT05668741) | Vertex Pharmaceuticals Incorporated | 2023-02-27 |
| Systemic Pharmacokinetic Study of T4032 (Unpreserved Bimatoprost 0.01%) Eye Gel Versus Lumigan® 0.01% Eye Drops in 40 Healthy Volunteers (NCT05729594) | Laboratoires Thea | 2023-02-27 |
| LX102 in Patients With Neovascular Age-Related Macular Degeneration (nAMD) (NCT06198413) | Innostellar Biotherapeutics Co.,Ltd | 2023-02-27 |
| A Dose Escalation Study of IBI333 in Subjects With Neovascular Age-related Macular Degeneration (NCT05639530) | Innovent Biologics (Suzhou) Co. Ltd. | 2023-02-27 |
| Pharmacokinetics and Safety/Tolerability of CKD-379 (NCT05719155) | Chong Kun Dang Pharmaceutical | 2023-02-27 |
| A Phase 1a/1b Study to Determine the Recommended Phase 2 Dose, of Tepotinib in Participants With MET Alterations and Brain Tumors (NCT05120960) | M.D. Anderson Cancer Center | 2023-02-27 |
| A Clinical Study to Investigate the Mass Balance and Biotransformation of [14C]DWP14012 in Healthy Chinese Male Subjects (NCT05868967) | Daewoong Pharmaceutical Co. LTD. | 2023-02-27 |
| R-3750 in Patients With Mild to Moderate Ulcerative Colitis (NCT05666960) | Rise Therapeutics LLC | 2023-02-27 |
| ZN-c3 in Adult Participants With Metastatic Colorectal Cancer (NCT05743036) | K-Group, Beta, Inc., a wholly owned subsidiary of Zentalis Pharmaceuticals, Inc | 2023-02-27 |
| The Effects of Topical Hyaluronic Acid and Laser Application on Wound Healing in Children (NCT05765240) | Atlas University | 2023-02-27 |
| Evaluation of the Walk With Ease Program for Fall Prevention (NCT05693025) | Iowa State University | 2023-02-27 |
| AT278, NovoRapid® and Humulin® R (U500) in Glucose Clamp Study (NCT05754424) | Arecor Limited | 2023-02-27 |
| Chemotherapy in Patients With Relapsed Small Cell Lung Cancer in Combination With Allopurinol and MycoPhenolate (CLAMP Trial) (NCT05049863) | Washington University School of Medicine | 2023-02-27 |
| A Pharmacokinetic Study of Intravenous and Intranasal Oxytocin in Healthy Subjects (NCT05672667) | Wake Forest University Health Sciences | 2023-02-27 |
| Study of Atezolizumab Plus BEGEV Regimen in Relapsed or Refractory Hodgkin's Lymphoma Patients (NCT05300282) | Fondazione Italiana Linfomi - ETS | 2023-02-27 |
| Study of AV-1959D, an Amyloid Beta Vaccine (NCT05642429) | Institute for Molecular Medicine | 2023-02-27 |
| Evaluation of the Pharmacokinetics and Safety of VX-548 in Participants With Renal Impairment (NCT05704556) | Vertex Pharmaceuticals Incorporated | 2023-02-27 |
| Evaluation of Safety and Efficacy of Gene Therapy Drug in the Treatment of Spinal Muscular Atrophy (SMA) Type 1 Patients (NCT05824169) | GeneCradle Inc | 2023-02-25 |
| Perioperative Nitric Oxide Prevents Acute Kidney Injury in Cardiac Surgery Patients With Chronic Kidney Disease (NCT05757557) | Tomsk National Research Medical Center of the Russian Academy of Sciences | 2023-02-25 |
| CART-EGFR-IL13Ra2 in EGFR Amplified Recurrent GBM (NCT05168423) | University of Pennsylvania | 2023-02-24 |
| Study to Demonstrate the Bioequivalence of Single Oral Administration of K-001 Relative to Single Oral Coadministration of Separate Tablets of K-877-ER and CSG452 (NCT05722262) | Kowa Research Institute, Inc. | 2023-02-24 |
| Clinical Study of AL2846 Capsule in the Treatment of Differentiated Thyroid Cancer (NCT05745363) | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | 2023-02-24 |
| A Study of ES014 in Patients With Locally Advanced or Metastatic Solid Tumours (NCT05717348) | Elpiscience (Suzhou) Biopharma, Ltd. | 2023-02-24 |
| Study to Evaluate JCXH-211 as Monotherapy in Patients With Malignant Solid Tumors (NCT05727839) | Immorna Biotherapeutics, Inc. | 2023-02-24 |
| A Study of Carbon-14-Labelled [14C] LY3372689 in Healthy Male Participants (NCT05749848) | Eli Lilly and Company | 2023-02-24 |
| A Study to Test How Different Doses of BI 1703880 in Combination With Ezabenlimab Are Tolerated in People With Different Types of Advanced Cancer (Solid Tumours) (NCT05471856) | Boehringer Ingelheim | 2023-02-24 |
| CD19-CART(Relma-cel) for Moderate to Severe Active Systemic Lupus Erythematosus (NCT05765006) | Shanghai Ming Ju Biotechnology Co., Ltd. | 2023-02-24 |
| This Study is to Compare and Evaluate the Safety and Pharmacokinetic Characteristics (PK) After Administration of DW6014 and Each Component(Empagliflozin and Metformin) in Healthy Adult Volunteers in Fast Condition. (NCT05823870) | Dong Wha Pharmaceutical Co. Ltd. | 2023-02-24 |
| Integration of the PD-L1 Inhibitor Atezolizumab and WT1/DC Vaccination Into Platinum/Pemetrexed-based First-line Treatment for Epithelioid Malignant Pleural Mesothelioma (NCT05765084) | University Hospital, Antwerp | 2023-02-24 |
| Safety/Tolerability, PK and Efficacy of IMB071703 Injection in Patients With Advanced Solid Tumors (NCT06292858) | Beijng Immunoah Pharma Tech Co., Ltd. | 2023-02-24 |
| Study to Assess the Safety and Efficacy of OCU410 for Geographic Atrophy (NCT06018558) | Ocugen | 2023-02-23 |
| Study of Safety, Tolerability, Pharmacodynamics and Pharmacokinetics of NIO752 in Early Alzheimer's Disease Participants (NCT05469360) | Novartis Pharmaceuticals | 2023-02-23 |
| Bioequivalence Study of Two Products of Apixaban 5mg Tablets in Healthy, Adult, Human Subjects (NCT06043297) | Humanis Saglık Anonim Sirketi | 2023-02-23 |
| Safety, Tolerability, Pharmacokinetics (PK), and Food Effect of MK-7762 in Healthy Adults (NCT05824091) | Gates Medical Research Institute | 2023-02-23 |
| A Study to Understand the Effect of Itraconazole on the Levels of a Study Medicine Called ARV-471 in Healthy Adults (NCT05538312) | Pfizer | 2023-02-23 |
| A Study of Siremadlin Alone and in Combination With Donor Lymphocyte Infusion in Acute Myeloid Leukemia Post-allogeneic Stem Cell Transplant (NCT05447663) | Novartis Pharmaceuticals | 2023-02-23 |
| IFNα Expressing Mesenchymal Stromal Cells for Locally Advanced/Metastatic Solid Tumors (NCT05699811) | Chinese PLA General Hospital | 2023-02-23 |
| Safety, Tolerability, Pharmacokinetic Characteristics, and Efficacy of CM369 in Advanced Solid Tumors & Hematologic Malignancies (NCT05690581) | Beijing InnoCare Pharma Tech Co., Ltd. | 2023-02-23 |
| VS-6766+Abema+Fulv in Met HR+/HER- BC (NCT05608252) | Adrienne G. Waks | 2023-02-23 |
| Study of Talazoparib in Combination With Chemotherapy in Relapsed Pediatric AML to Determine Safety and Efficacy (NCT05101551) | Norman J. Lacayo | 2023-02-23 |
| TACTIVE-U: A Study to Learn About the Study Medicine (Vepdegestrant) When Given With Other Medicines in People With Advanced or Metastatic Breast Cancer (Sub-Study A) (NCT05548127) | Pfizer | 2023-02-23 |
| Neoadjuvant PD-1 Plus TIGIT Blockade in Patients With Cisplatin-Ineligible Operable High-Risk Urothelial Carcinoma (NCT05394337) | M.D. Anderson Cancer Center | 2023-02-23 |
| Study of 19(T2)28z1xx TRAC-Chimeric Antigen Receptor (CAR) T Cells in People With B-Cell Lymphoma (NCT05757700) | Memorial Sloan Kettering Cancer Center | 2023-02-23 |
| SC0245 and Irinotecan in Treating Patients With Relapsed Extensive-Stage Small Cell Lung Cancer (ES-SCLC) (NCT05731518) | Biocity Biopharmaceutics Co., Ltd. | 2023-02-23 |
| Safety and Efficacy of the Bacteriophage Preparation, ShigActive™, in a Human Experimental Model of Shigellosis (NCT05182749) | Intralytix, Inc. | 2023-02-23 |
| LEV102 Topical Gel in Acquired Blepharoptosis (NCT05715346) | Levation Pharma, Ltd. | 2023-02-23 |
| Phase Ib/IIa Trial With AC01 in Patients With HFrEF (NCT05642507) | AnaCardio AB | 2023-02-23 |
| A Study Comparing Trifarotene Cream 0.005% to AKLIEF® Cream in the Treatment of Acne Vulgaris (NCT06063473) | Sun Pharmaceutical Industries, Inc. | 2023-02-22 |
| A Study of C-CAR039 (Prizloncabtagene Autoleucel) in Patients With Relapsed/Refractory Large B-Cell Lymphoma (NCT05800977) | Shanghai AbelZeta Ltd. | 2023-02-22 |
| A Study of an MMSET Inhibitor in Patients With Relapsed and Refractory Multiple Myeloma (NCT05651932) | K36 Therapeutics, Inc. | 2023-02-22 |
| A Drug-Drug Interaction Study to Examine the Impact of Itraconazole and Cyclosporine on PF-07081532 Pharmacokinetics in Overweight or Obese Adults (NCT05745701) | Pfizer | 2023-02-22 |
| Ex Vivo Drug Sensitivity Testing and Multi-Omics Profiling (NCT05857969) | Florida International University | 2023-02-22 |
| A Study of AC176 for the Treatment of Metastatic Castration Resistant Prostate Cancer (NCT05673109) | Accutar Biotechnology Inc | 2023-02-22 |
| A Study of Tolinapant in Combination With Oral Decitabine/Cedazuridine and Oral Decitabine/Cedazuridine Alone in Participants With Relapsed/Refractory Peripheral T-cell Lymphoma (R/R PTCL) (NCT05403450) | Taiho Oncology, Inc. | 2023-02-22 |
| ASKB589 in Combination With CAPOX and PD-1 Inhibitors in Patients With Advanced, and Unresectable G/GEJ Cancer. (NCT05632939) | AskGene Pharma, Inc. | 2023-02-21 |
| Non-invasive Measurement of PD-L1 Levels With Positron Emission Tomography (PET) in Head and Neck Malignancies and Intracranial Metastases (NCT05408871) | Yale University | 2023-02-21 |
| APPRAISE 2.0: Live Trial of the APPRAISE Trauma Decision Support System (NCT06121661) | Andrew Tomas Reisner | 2023-02-21 |
| A Clinical Trial to Investigate the Safety, Tolerability, Pharmacokinetics, and Immunogenicity of Single and Multiple Ascending Doses of ARGX-119 in Healthy Participants (NCT05670704) | argenx | 2023-02-21 |
| A Study of Navenibart (STAR-0215) in Participants With Hereditary Angioedema (NCT05695248) | Astria Therapeutics, Inc. | 2023-02-21 |
| A Study to Test How BI 690517 is Taken up in the Body of People With and Without Liver Problems (NCT05731908) | Boehringer Ingelheim | 2023-02-21 |
| Bioequivalence Study to Compare Metformin / Vildagliptin (850 mg/50 mg) Versus Galvumet® (NCT06103747) | Reseach Laboratory of Clinical and Experimental Pharmacology | 2023-02-21 |
| A Study of GNC-038 Injection in Patients With Relapsed or Refractory NK/ T-cell Lymphoma, AITL, and Other NHL (NCT05627856) | Sichuan Baili Pharmaceutical Co., Ltd. | 2023-02-21 |
| A Phase I/II Study of GLB-COV2-043 as a COVID-19 Vaccine Booster (NCT05602961) | GreenLight Biosciences, Inc. | 2023-02-21 |
| A Phase I Dosing Study of IkT-148009. (NCT06641557) | ABLi Therapeutics, Inc. | 2023-02-21 |
| NOMINATE/ Minimisation of Immunosuppression in Kidney Transplantation (NCT05073822) | University College, London | 2023-02-20 |
| Remote Resistance Exercise Powering Survivors - Gastrointestinal Oncology (NCT05664178) | H. Lee Moffitt Cancer Center and Research Institute | 2023-02-20 |
| A Study to Evaluate the Effects of Mavacamten in Healthy Participants (NCT05719805) | Bristol-Myers Squibb | 2023-02-20 |
| Intra-ovarian Injection of MSC-EVs in Idiopathic Premature Ovarian Failure (NCT06202547) | Royan Institute | 2023-02-20 |
| Sequenced Treatment Alternatives to Relieve Adolescent Depression (STAR-AD) (NCT05814640) | First Affiliated Hospital of Chongqing Medical University | 2023-02-20 |
| A Study To Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of E2086 in Healthy Adult and Elderly Participants (NCT05745207) | Eisai Inc. | 2023-02-20 |
| Study to Assess Safety and Efficacy of AsiDNA in Combination with Olaparib in Participants with Recurrent Solid Tumors (NCT05700669) | Valerio Therapeutics | 2023-02-20 |
| A Phase Ia Safety and Tolerability Study of BL-001 (NCT05818306) | Bloom Science | 2023-02-20 |
| A Study of Mezigdomide in Healthy Participants and Participants With Hepatic Impairment (NCT05707390) | Bristol-Myers Squibb | 2023-02-20 |
| Study to Investigate Hepatic Impairment on PK, Safety, Tolerability of Camizestrant in Post-Menopausal Female Subjects (NCT05790304) | AstraZeneca | 2023-02-20 |
| Safety and Efficacy of ZVS101e in Patients With Bietti 's Crystalline Dystrophy (NCT05832684) | Chigenovo Co., Ltd | 2023-02-20 |
| A Study to Learn About the Study Medicine Called Vepdegestrant (ARV-471, PF-07850327) in People With ER+/HER2- Advanced Breast Cancer in China (NCT05732428) | Pfizer | 2023-02-20 |